Beersma M F, Galama J M, Van Druten H A, Renier W O, Lucas C J, Kapsenberg J G
Department of Medical Microbiology, University of Amsterdam, The Netherlands.
Int J Epidemiol. 1992 Jun;21(3):583-8. doi: 10.1093/ije/21.3.583.
Since 1976, when general immunization against measles was introduced in the Netherlands, all new cases of subacute sclerosing panencephalitis (SSPE) were registered and detailed data about immunization, epidemiology and disease progression were collected on them. Up to 1991, 99 new patients have been registered of which 81 were born in this country and 18 elsewhere. From 1981 onwards, the incidence of SSPE among those born in the Netherlands decreased gradually from 13 cases per year to one case per year. This decrease is attributed to the large scale of immunization against measles. Three SSPE patients had been immunized against measles, all of them without a history of clinical measles. Epidemiology and risk factors of SSPE did not differ from those reported in other countries. An exceptional cluster of four patients in one town, who had measles in the same year, is reported. Progression of SSPE appeared to be age related. A total of 28 patients was treated with Inosiplex; no significant effect on survival in stage 3 of the disease was found.
自1976年荷兰引入麻疹全面免疫接种以来,所有亚急性硬化性全脑炎(SSPE)新病例均被登记,并收集了有关免疫接种、流行病学和疾病进展的详细数据。截至1991年,已登记99例新患者,其中81例在该国出生,18例在其他地方出生。从1981年起,荷兰出生人群中SSPE的发病率从每年13例逐渐降至每年1例。这种下降归因于大规模的麻疹免疫接种。3例SSPE患者曾接种过麻疹疫苗,他们均无临床麻疹病史。SSPE的流行病学和危险因素与其他国家报告的情况无异。报告了在一个城镇出现的4例同年患麻疹的特殊病例群。SSPE的进展似乎与年龄有关。共有28例患者接受了肌苷治疗;未发现对疾病3期的生存率有显著影响。